Primary |
Infantile Spasms |
66.7% |
Complex Partial Seizures |
11.1% |
Lennox-gastaut Syndrome |
11.1% |
Quadriparesis |
11.1% |
|
Convulsion |
20.0% |
Dystonia |
20.0% |
Movement Disorder |
20.0% |
Opisthotonus |
20.0% |
Thrombocytopenia |
20.0% |
|
Secondary |
Epilepsy |
35.2% |
Convulsion |
12.6% |
Product Used For Unknown Indication |
8.2% |
Status Epilepticus |
7.3% |
Partial Seizures |
6.4% |
Foetal Exposure During Pregnancy |
3.9% |
Grand Mal Convulsion |
3.4% |
Lennox-gastaut Syndrome |
3.4% |
Drug Use For Unknown Indication |
3.0% |
Infantile Spasms |
3.0% |
Drug Exposure During Pregnancy |
2.1% |
Asthenia |
1.6% |
Dyspnoea |
1.6% |
Pyrexia |
1.6% |
Tuberous Sclerosis |
1.6% |
Breast Cancer Metastatic |
1.4% |
Diabetes Mellitus |
1.4% |
Complex Partial Seizures |
0.9% |
Petit Mal Epilepsy |
0.9% |
Porphyria Acute |
0.7% |
|
Status Epilepticus |
15.0% |
Drug Exposure During Pregnancy |
8.3% |
Hydronephrosis |
6.7% |
Neonatal Behavioural Syndrome |
6.7% |
Sudden Unexplained Death In Epilepsy |
6.7% |
Drug Ineffective |
5.0% |
Osteoporosis |
5.0% |
Partial Seizures |
5.0% |
Suicide Attempt |
5.0% |
Vomiting |
5.0% |
Inappropriate Antidiuretic Hormone Secretion |
3.3% |
Maternal Exposure During Pregnancy |
3.3% |
Normal Newborn |
3.3% |
Nuclear Magnetic Resonance Imaging Brain Abnormal |
3.3% |
Penis Disorder |
3.3% |
Petit Mal Epilepsy |
3.3% |
Pneumonia |
3.3% |
Swelling Face |
3.3% |
Vesicoureteric Reflux |
3.3% |
Complex Partial Seizures |
1.7% |
|
Concomitant |
Epilepsy |
58.5% |
Drug Use For Unknown Indication |
7.4% |
Infantile Spasms |
6.8% |
Convulsion |
5.9% |
Product Used For Unknown Indication |
3.8% |
Gastrooesophageal Reflux Disease |
2.7% |
Lennox-gastaut Syndrome |
1.9% |
Grand Mal Convulsion |
1.6% |
Partial Seizures |
1.6% |
Tuberous Sclerosis |
1.4% |
Myoclonic Epilepsy |
1.3% |
Prophylaxis |
1.1% |
Asthma |
0.9% |
Blood Pressure |
0.9% |
Insomnia |
0.9% |
Pneumonia |
0.9% |
Early Infantile Epileptic Encephalopathy With Burst-suppression |
0.8% |
Astrocytoma, Low Grade |
0.5% |
Breast Cancer Metastatic |
0.5% |
Bronchopulmonary Dysplasia |
0.5% |
|
Vomiting |
15.1% |
Tracheo-oesophageal Fistula |
12.3% |
Vesicoureteric Reflux |
9.4% |
Convulsion |
6.6% |
Thrombocytopenia |
6.6% |
Epilepsy |
5.7% |
Pallor |
5.7% |
Somnolence |
5.7% |
Pyrexia |
4.7% |
Drug Interaction |
3.8% |
Status Epilepticus |
3.8% |
Cough |
2.8% |
Drug Ineffective |
2.8% |
Hypoglycaemia |
2.8% |
Hypotonia |
2.8% |
Death |
1.9% |
Hydronephrosis |
1.9% |
Pulmonary Hypertension |
1.9% |
Renal Failure |
1.9% |
Respiratory Distress |
1.9% |
|
Interacting |
|
Drug Interaction |
50.0% |
Urinary Incontinence |
50.0% |
|